Clinical Trial Update: Booster Dose of sIPV Co-administered With MMR and HepA-I. [Phase 4]

View source ↗

Summary

Phase 4 booster-dose trial evaluating co-administration of sIPV with MMR and HepA-I has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• HepA-I (Hepatitis A vaccine, inactivated)
• MMR vaccine (Measles, Mumps, and Rubella vaccine)
• sIPV (Sabin inactivated polio vaccine)

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Poliomyelitis | Phase 4 | Status: COMPLETED